Head of Drug Discovery Sciences
Exelixis
Alameda, California
Dr. Jae H. Chang received his Ph.D. in the department of Pharmaceutical Sciences at the University of California, San Francisco, where he investigated the impact of drug transporters in gut metabolism, specifically of glucuronidation. He has successfully contributed to the progression of many compounds in diverse therapeutic areas through the preclinical and clinical stages, and currently is the Head of Drug Discovery Sciences at Exelixis. His research interests consist of evaluating the impact of fundamental pharmacokinetic parameters on the disposition of compounds, with the goal of driving discovery programs and applying this knowledge to enhance the profile of clinical candidates. In addition, his interests have expanded to explore the potential application of drug metabolizing enzymes and drug transporters in better understanding toxicity. His research has resulted in many impactful publications and he is a frequent presenter at national and international conferences.
Disclosure information not submitted.
Tuesday, October 18, 2022
1:30 PM – 2:30 PM ET